(Q42612036)

3 November 2017

title

Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis (English)

1 reference

chronic inflammatory demyelinating polyradiculoneuropathy

3 November 2017

main subject

0 references

inflammation

0 references

author name string

D Cocito

1

1 reference

3 November 2017

S Grimaldi

2

1 reference

3 November 2017

I Paolasso

3

1 reference

3 November 2017

Y Falcone

4

1 reference

3 November 2017

G Antonini

5

1 reference

3 November 2017

L Benedetti

6

1 reference

3 November 2017

C Briani

7

1 reference

3 November 2017

R Fazio

8

1 reference

3 November 2017

S Jann

9

1 reference

3 November 2017

S Matà

10

1 reference

3 November 2017

M Sabatelli

11

1 reference

3 November 2017

E Nobile-Orazio

12

1 reference

3 November 2017

Italian Network for CIDP Register

13

1 reference

3 November 2017

publication date

5 August 2011

1 reference

European Journal of Neurology

3 November 2017

published in

1 reference

3 November 2017

volume

18

1 reference

3 November 2017

issue

12

1 reference

3 November 2017

page(s)

1417-1421

1 reference

Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03495.X

Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03495.X

Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03495.X

Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03495.X

Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03495.X

Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03495.X

Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03495.X

Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03495.X

A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03495.X

Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: treatment update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03495.X

10.1111/J.1468-1331.2011.03495.X

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference